The application of CD10 inhibitors has been shown to suppress CRC cell proliferation by inducing cell cycle arrest in the G0/G1 phase, stimulating ERK1/2, and decreasing the phosphorylation of mTOR, 4E-BP1, and p70S6K. This evidence concerns the gene MME and colorectal carcinoma.